Inside Drug Pricing - 03/11/2019

Gottlieb Says Part D Needs Competition; Doesn’t Mention IPI, Rx Imports

March 06, 2019
Outgoing FDA Commissioner Scott Gottlieb said Wednesday (March 6) that Medicare should inject private negotiation into Medicare Part B, which is in line with HHS’ original plan to design Part B like the retail drug benefit Part D, but he did not mention the current plan to reference foreign drug prices in Part B. Some drug lobbyists -- though not all -- think Gottlieb is leaving to avoid being associated with proposed policies they say he opposes, including the International...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.